You can buy or sell Agenus and other stocks, options, ETFs, and crypto commission-free!
Agenus Inc. Common Stock, also called Agenus, is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Read More Its product pipeline includes AGEN1884, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.
52 Week High
52 Week Low
— per share
Expected May 7, Pre-Market